BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34285256)

  • 21. High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis.
    Iwamoto T; Dorschner JM; Selvaraj S; Mezzano V; Jensen MA; Vsetecka D; Amin S; Makol A; Osborn T; Moder K; Chowdhary VR; Izmirly P; Belmont HM; Clancy RM; Buyon JP; Wu M; Loomis CA; Niewold TB
    J Rheumatol; 2022 Apr; 49(4):388-397. PubMed ID: 34782453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney Tertiary Lymphoid Structures in Lupus Nephritis Develop into Large Interconnected Networks and Resemble Lymph Nodes in Gene Signature.
    Dorraji SE; Kanapathippillai P; Hovd AK; Stenersrød MR; Horvei KD; Ursvik A; Figenschau SL; Thiyagarajan D; Fenton CG; Pedersen HL; Fenton KA
    Am J Pathol; 2020 Nov; 190(11):2203-2225. PubMed ID: 32818496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics Analysis of the Core Genes Related to Lupus Nephritis Through a Network and Pathway-Based Approach.
    Sun G; Zhu P; Dai Y; Chen W
    DNA Cell Biol; 2019 Jul; 38(7):639-650. PubMed ID: 31090450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.
    Bethunaickan R; Berthier CC; Zhang W; Kretzler M; Davidson A
    PLoS One; 2013; 8(10):e77489. PubMed ID: 24167575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus.
    Alves I; Santos-Pereira B; Dalebout H; Santos S; Vicente MM; Campar A; Thepaut M; Fieschi F; Strahl S; Boyaval F; Vizcaíno R; Silva R; Holst-Bernal S; Vasconcelos C; Santos L; Wuhrer M; Marinho A; Heijs B; Pinho SS
    Arthritis Rheumatol; 2021 Nov; 73(11):2069-2077. PubMed ID: 33881228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
    Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
    JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tight correlation of 5-hydroxymethylcytosine expression with the scarring damage of discoid lupus erythematosus.
    Li Q; Yang M; Chen K; Zhou S; Zhou S; Wu H
    Lupus; 2022 Oct; 31(11):1306-1316. PubMed ID: 35817588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular imaging of the kidney in lupus nephritis to characterize response to treatment.
    Parikh SV; Malvar A; Song H; Alberton V; Lococo B; Vance J; Zhang J; Yu L; Birmingham D; Rovin BH
    Transl Res; 2017 Apr; 182():1-13. PubMed ID: 27842222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis.
    Olivares D; Perez-Hernandez J; Forner MJ; Perez-Soriano C; Tormos MC; Saez GT; Chaves FJ; Redon J; Cortes R
    Clin Sci (Lond); 2018 Mar; 132(5):569-579. PubMed ID: 29440621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus.
    Zheng M; Hu Z; Mei X; Ouyang L; Song Y; Zhou W; Kong Y; Wu R; Rao S; Long H; Shi W; Jing H; Lu S; Wu H; Jia S; Lu Q; Zhao M
    Nat Commun; 2022 Dec; 13(1):7489. PubMed ID: 36470882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis.
    Wardowska A; Komorniczak M; Bułło-Piontecka B; Dȩbska-Ślizień MA; Pikuła M
    Front Immunol; 2019; 10():2026. PubMed ID: 31507612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
    Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
    Front Immunol; 2021; 12():747616. PubMed ID: 34745118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis.
    Xue L; Liu L; Huang J; Wen J; Yang R; Bo L; Tang M; Zhang Y; Liu Z
    Biomed Res Int; 2017; 2017():4927376. PubMed ID: 29333443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus.
    Xiang M; Chen Q; Feng Y; Wang Y; Wang J; Liang J; Xu J
    Lupus; 2021 Apr; 30(5):807-817. PubMed ID: 33530816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide differential expression reveals candidate genes involved in the pathogenesis of lupus and lupus nephritis.
    AlFadhli S; Ghanem AA; Nizam R
    Int J Rheum Dis; 2016 Jan; 19(1):55-64. PubMed ID: 26403095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics.
    Hu W; Chen X
    Sci Rep; 2022 Nov; 12(1):18826. PubMed ID: 36335193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
    Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
    Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.
    Qi H; Xu L; Liu Q
    Mol Med; 2023 Jul; 29(1):99. PubMed ID: 37488524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.